PMV Pharmaceuticals, Inc. — Director's Dealing 2025

Mar 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-03-03

Reporting Person: Jalota Deepika (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-03	Employee Stock Option (right to buy)	$1.32	A	300000	Acquired	2035-03-03	Common Stock (300000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	123024	Direct

Footnotes

F1: Includes 4,741 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,276 shares acquired on May 20, 2021; 359 shares acquired on November 19, 2021; 993 shares acquired on May 20, 2022 and 1,113 shares acquired on November 21, 2022.

F2: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.